Formation of a Human β-Cell Population within Pancreatic Islets Is Set Early in Life
Open accessThe DOI matches its Crossref record; 43 of the 50 references it cites were found in a registry or an index.
Abstract
CONTEXT: Insulin resistance can be compensated by increased functional pancreatic β-cell mass; otherwise, diabetes ensues. Such compensation depends not only on environmental and genetic factors but also on the baseline β-cell mass from which the expansion originates. OBJECTIVE: Little is known about assembly of a baseline β-cell mass in humans. Here, we examined formation of β-cell populations relative to other pancreatic islet cell types and associated neurons throughout the normal human lifespan. DESIGN AND METHODS: Human pancreatic sections derived from normal cadavers aged 24 wk premature to 72 yr were examined by immunofluorescence. Insulin, glucagon, and somatostatin were used as markers for β-, α-, and δ-cells, respectively. Cytokeratin-19 marked ductal cells, Ki67 cell proliferation, and Tuj1 (neuronal class III β-tubulin) marked neurons. RESULTS: Most β-cell neogenesis was observed preterm with a burst of β-cell proliferation peaking within the first 2 yr of life. Thereafter, little indication of β-cell growth was observed. Postnatal proliferation of α- and δ-cells was rarely seen, but a wave of ductal cell proliferation was found mostly associated with exocrine cell expansion. The β-cell to α-cell ratio doubled neonatally, reflecting increased growth of β-cells, but during childhood, there was a 7-fold change in the β-cell to δ-cell ratio, reflecting an additional loss of δ-cells. A close association of neurons to pancreatic islets was noted developmentally and retained throughout adulthood. Negligible neuronal association to exocrine pancreas was observed. CONCLUSION: Human baseline β-cell population and appropriate association with other islet cell types is established before 5 yr of age.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Both of these concepts of pathogenesis of type 1 diabetes have been debated.50,51”
From Type 1 diabetes (2014) · cites this paper as [51]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Recent data suggest that although most patients with longstanding type 1 diabetes have few β cells, if any, there is evidence for β-cell regeneration in infants and very young children (but not in adolescents or adults).51,52”
From Type 1 diabetes (2014) · cites this paper as [51]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“β-Cell mass increases during the first decade of life due to proliferation during the first 5 years ( 53 , 54 ), stabilizing during adolescence with considerable variation (three- to fivefold) unrelated to age or BMI.”
From β-Cell Failure in Type 2 Diabetes: Postulated Mechanisms and Prospects for Prevention and Treatment (2014) · cites this paper as [53]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Through these and other studies, analyses of pancreata from individuals with recent-onset type 1 diabetes suggest that around 70% of islets display complete insulin absence;51,52”
From Type 1 diabetes (2014) · cites this paper as [51]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pathogenesis of type 2 diabetes mellitus
DeFronzo, R. A. (2004) · Medical Clinics of North America · doi:10.1016/j.mcna.2004.04.013 · Cited by 1,342
Type 2 Diabetes-a Matter of ß-Cell Life and Death?
Rhodes, C. J. (2005) · Science · doi:10.1126/science.1104345 · Cited by 896
Self-citationBrissova, M., Fowler, M. J., Nicholson, W. E., Chu, A., Hirshberg, B., Harlan, D. M., & Powers, A. C. (2005) · Journal of Histochemistry & Cytochemistry · doi:10.1369/jhc.5c6684.2005 · Cited by 797
Meier, J. J., Butler, A. E., Saisho, Y., Monchamp, T., Galasso, R., Bhushan, A., Rizza, R. A., & Butler, P. C. (2008) · Diabetes · doi:10.2337/db07-1369 · Cited by 683
Intrauterine Growth Retardation Leads to the Development of Type 2 Diabetes in the Rat
Simmons, R. A., Templeton, L. J., & Gertz, S. J. (2001) · Diabetes · doi:10.2337/diabetes.50.10.2279 · Cited by 638
Sorenson, R., & Brelje, T. (1997) · Hormone and Metabolic Research · doi:10.1055/s-2007-979040 · Cited by 531
Pathogenesis of Type 2 Diabetes Mellitus
Leahy, J. L. (2005) · Archives of Medical Research · doi:10.1016/j.arcmed.2005.01.003 · Cited by 469
Brissova, M., Shostak, A., Shiota, M., Wiebe, P. O., Poffenberger, G., Kantz, J., Chen, Z., Carr, C., Jerome, W. G., Chen, J., et al. (2006) · Diabetes · doi:10.2337/db06-0690 · Cited by 442
Adaptive changes in pancreatic beta cell fractional area and beta cell turnover in human pregnancy
Butler, A. E., Cao-Minh, L., Galasso, R., Rizza, R. A., Corradin, A., Cobelli, C., & Butler, P. C. (2010) · Diabetologia · doi:10.1007/s00125-010-1809-6 · Cited by 435
Studies on the pancreas of the guinea pig
Bensley, R. R. (1911) · American Journal of Anatomy · doi:10.1002/aja.1000120304 · Cited by 426
Cited by
Items 301–344 of 344
Mah, E. M., Ngwanou, D. H., Suzanne, N. U. S., Maguip, L., David, C., Temgoua, M. N., Gides, Z., Chiabi, A., & Forbushi, A. I. F. (2020) · Open Journal of Pediatrics · doi:10.4236/ojped.2020.104069 · Cited by 1
Abdelhamid, A., Youssef, M., & Saber, S. (2022) · Delta University Scientific Journal · doi:10.21608/dusj.2022.275439 · Cited by 2
Abbas, M. A., Morsy, M. A., Rahman, R. E. A., El-Kousy, S. M., Abdul-Azim, T. R., Elsayed, H. M., & Badr, E. A. E. (2023) · Human Gene · doi:10.1016/j.humgen.2023.201191 · Cited by 1
Tsaitlin-Mor, L., Cahen‐Peretz, A., Bentov, Y., Ben‐Shushan, T., Levine, H., & Walfisch, A. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad715 · Cited by 1
Sweet Spot Regulation of Maternal Metabolic Health and Nutrition on β-Cell Mass in the Offspring
Chung, G., Wong, A., Her, T. K., & Alejandro, E. U. (2024) · Advances in anatomy, embryology and cell biology · doi:10.1007/978-3-031-62232-8_7 · Cited by 1
Pancreatic β-Cell Senescence: A Contributor to Type 2 Diabetes
Urmi, R., Singh, R., Singh, M., & Sinha, B. K. (2025) · Springer eBooks · doi:10.1007/978-981-96-1041-9_8 · Cited by 1
Architecture and Morphology of Human Pancreatic Islets
Powers, A. C. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-408134-5.00016-0 · Cited by 2
Strategies to promote beta-cell replication and regeneration
Xiao, X. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814831-0.00014-2 · Cited by 1
Development and maintenance of the islet β cell
Mastracci, T. L., Mirmira, R. G., & Anderson, R. M. (2015) · Wiley eBooks · doi:10.1002/9781118387658.ch4 · Cited by 1
Glucagon in Islet and Metabolic Regulation
Sandoval, D. A., Tong, J., & Alessio, D. D. (2016) · Wiley eBooks · doi:10.1002/9781118924853.ch7 · Cited by 1
Zhang, J. A., Gu, C., Smith, D. K., Kong-Beltran, M., Kljavin, N. M., Ngu, H., Suriben, R., Stinson, J., Modrusan, Z. D., & Peterson, A. S. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/303263 · Cited by 1
“After birth, replication of pre-existing, insulin expressing β cells is the predominant means for β cell mass increase in both humans and rodents (Dor et al. 2004; Brennand et al. 2007; Nir et al. 2007; Teta et al. 2007; Gregg et al. 2012).”
BackgroundHoyeck, M. P. (2023) · Carleton University's Institutional Repository (MacOdrum Library, Carleton University) · doi:10.22215/etd/2023-15835 · Cited by 1
Koblas, T., Bittenglová, K., Abaffy, P., Zacharovová, K., Girman, P., Valihrach, L., Kříž, J., & Saudek, F. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.08.21.746224 · Cited by 1
Heterogeneity in cell-cycle dynamics of synthetic mRNA-induced β-cell proliferationPreprint
Bittenglová, K., Zacharovová, K., Tichánek, F., Leontovyč, I., Girman, P., Kříž, J., Saudek, F., & Koblas, T. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.09.11.750925
“( Cnop et al , 2010) In humans, β-31 cells proliferation peaks during the neonatal period and declines gradually after early childhood to approximately 0.5% or less (Gregg et al , 2012).”
InfluentialKrentz, A. J., Heinemann, L., & Hompesch, M. (2014) · Springer eBooks · doi:10.1007/978-1-4471-4920-0_2
Protein expression analysis of Insulin producing cells exposed to endoplasmic reticulum stress
Rosengren, V. (2015) · Figshare · Cited by 1
Stress-inducible Mig6 promotes pancreatic beta cell destruction in the pathogenesis of diabetes
Chen, Y. (2014) · IUScholarWorks (Indiana University) · doi:10.7912/c2/2003
Mechanisms of transcriptional regulation in the maintenance of β cell function
Maganti, A. V. (2015) · IUScholarWorks (Indiana University) · doi:10.7912/c2b88b
“ChoP, a bZip transcription factor, inhibits transcription of (186) anti-apoptotic Bcl2 proteins (151) and induces pro-apoptotic proteins such as the negative feedback inhibitor of eIF2α phosphorylation, Gadd34 (152), the Akt inhibitor, Trb3 (153) to promote cell apoptosis.”
BackgroundYang, Y., & Chan, L. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800563-7.00008-7
Zhang, Y., & Hesselson, D. (2016) · eLife · doi:10.7554/elife.23065
“By two years of age, the proliferation of b cells in humans slows markedly (Gregg et al., 2012), which suggests that the proliferation of perinatal b cells may be important for establishing a reserve of b cells to promote lifelong metabolic health (Berger et al., 2015).”
BackgroundCloning and characterization of IA-2 specific autoantibodies in Type 1 diabetes
Johnson, C. (2016) · Research Portal (King's College London)
Association of Leg Length with Metabolic Abnormalities Underlying Type 2 Diabetes Mellitus
Johnston, L. (2013) · TSpace (University of Toronto)
Ontogeny of the Human Pancreas
Proshchina, A. E., Krivova, Y. S., Gurevich, L. E., Barabanov, V. M., Otlyga, D., Voronkova, I. А., & Saveliev, S. V. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.84515
“In humans, the main mechanism by which the endocrine pancreas grows during the neonatal period is an increase in the islet size rather than their number [35, 36], i.”
BackgroundInfluentialPediatric Diabetes: Review Article
Bavishna, B., Devi, R. U., & Krishnan, S. G. (2019) · Indian Journal of Public Health Research & Development · doi:10.5958/0976-5506.2019.04013.0
Martjanova, M. V., & Babenko, A. Y. (2020) · Meditsinskiy sovet = Medical Council · doi:10.21518/2079-701x-2020-7-50-55
Clinically Relevant Mathematical Model for the BCG-based Treatment Of Type 1 DiabetesPreprint
Lazebnik, T., Bunimovich‐Mendrazitsky, S., & Kiselyov, A. S. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.09.02.458659
Glucagon in Islet and Metabolic Regulation
Campbell, J. E., & D’Alessio, D. A. (2024) · Wiley eBooks · doi:10.1002/9781119697473.ch8
A novel dual DYRK1A/B inhibitor for the treatment of type 1 diabetes
Tumas, Š., Mingaila, J., Baranauskas, V., Baltrukonytė, E., Orla, L., Kraśko, J. A., Pocevičiūtė, R., Berlina, D., Belenky, A., Vilenchik, M., et al. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1657042
Gudmestad, J. H., Unger, L., Paulo, J. A., Ghila, L., & Legøy, T. A. (2025) · Toxicological Sciences · doi:10.1093/toxsci/kfaf163
“This apparent advantage is likely also their weakness, as beta-cells in vivo have a low ability to proliferate (Gregg et al. 2012).”
Darwish, R., Alcibahy, Y., Nandakumar, M., Butler, A. E., & Moin, A. S. M. (2025) · Stem Cell Research & Therapy · doi:10.1186/s13287-025-04739-y
“In adolescence and adulthood, β-cell proliferation became rare, remaining consistently below 0.5% [13, 14].”
InfluentialER stress relief drives ß-cell proliferationPreprint
Bourgeois, S., Mulders, A. V., Heremans, Y., Leuckx, G., Willems, L., Coenen, S., Degroote, L., Pierreux, J., Kancheva, D., Scheyltjens, I., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.09.06.611615
Generation and Validation of an Aryl Hydrocarbon Receptor Knockout Human Embryonic Stem Cell Line
Gang, N., Nian, C., Filatov, E., Zhang, D., Hoyeck, M. P., Laforest, B., Lynn, F. C., & Bruin, J. E. (2026) · Endocrinology · doi:10.1210/endocr/bqaf189 · Cited by 1
Blood glucose homeostasis in patients with mild to moderate Spinocerebellar Ataxia type 2Preprint
Aguilera‐Rodríguez, R., Almaguer‐Gotay, D., Sosa, A. Á., Anidos-Machado, M., Silva-Ricardo, Y., Cuello‐Almarales, D., Estupiñán‐Rodríguez, A., & Almaguer‐Mederos, L. E. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.01.25.701567
Placental secretome: uncovering the vast signals shaping fetal metabolic health trajectory
Jo, S., Alejandro, E. U., & Beetch, M. (2026) · Current Opinion in Physiology · doi:10.1016/j.cophys.2026.100944
Les cellules MAIT dans le diabète de type 1 chez l'homme
Nel, I. (2019) · theses.fr (ABES) · doi:10.70675/8eaa5bd8z1217z4729z8c2ezb385e0dbc1a9
Rôle des Sérine/Thréonine Kinases dans la cellule bêta pancréatique
Tenenbaum, M. (2018) · theses.fr (ABES) · doi:10.70675/f6355ceazdfe4z4dc2za371z03c7f4f2206b
Birth weight shapes renal damage from prolonged endurance activity later in life
Murray, A. A., Longman, D. P., Brown, E. L., Nowak, T. J., Muehlenbein, M. P., Wells, J. C. K., & Stock, J. T. (2026) · Frontiers in Ecology and Evolution · doi:10.3389/fevo.2026.1800460
Aguilera‐Rodríguez, R., Almaguer‐Gotay, D., Sosa, A. Á., Anidos-Machado, M., Silva-Ricardo, Y., Cuello‐Almarales, D., Estupiñán‐Rodríguez, A., & Almaguer‐Mederos, L. E. (2026) · The Cerebellum · doi:10.1007/s12311-026-02076-1
Structural and functional impact of cystic fibrosis on endocrine pancreatic innervation
Sun, X., Yi, Y., Hu, S., Novbatova, G., Uç, A., Ode, K. L., Engelhardt, J. F., & Norris, A. W. (2026) · Clinical Science · doi:10.1042/cs20260182
“As previously described [34,35], beta-cells in the human CON pancreas exhibited a degree of TUJ1 staining.”
Regulation of pancreatic beta-cell mass and its importance for antidiabetic therapies
Lenzen, S. (2026) · Journal of Molecular Medicine · doi:10.1007/s00109-026-02716-3
“In humans, it is even lower, between 0.1% and 0.2% per day [for review, see 1, 2].”
InfluentialWokasch, A. S., Shamoon, M., Campbell, C., Wu, T., Fuhr, J. D., Gilbert, A., Mehaffey, T. M., Barnes, C. M., Ahuja, N., Gingerich, M. A., et al. (2026) · Development · doi:10.1242/dev.205842
“Developmental mechanisms that affect the mass of pancreatic insulin-secreting β cells at birth can influence susceptibility to diabetes later in life (Gregg et al., 2012; Linnemann et al., 2014).”
Fibroblast growth factor in pancreatic development, homeostasis, and disease
Dou, Z., Jian, Y., Liu, X., Liu, Z., 刘会生, Lin, H., & Guo, Y. (2026) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2026.101535
BindingDB (2024) · UC San Diego · doi:10.7270/q2zg6xfd
Metadata
- Authors
- Gregg, B. E., Moore, P. C., Demozay, D., Hall, B. A., Li, M., Husain, A., Wright, A. J., Atkinson, M. A., & Rhodes, C. J.
- Affiliations
- University of Chicago (US)
- The Kovler Diabetes Center (B.E.G., P.C.M., D.D., B.A.H., C.J.R.), Chicago, Illinois 60637
- University of Florida Health (US)
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2012-09-01
- Volume
- 97
- Issue
- 9
- Pages
- 3197-3206
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- PMC
- PMC3431572
- OpenAlex
- W2143050701
- Cited by
- 344
- References
- 50
- Citations by year
- 2026: 18 · 2025: 27 · 2024: 20 · 2023: 23 · 2022: 26 · 2021: 31 · 2020: 26 · 2019: 25 · 2018: 26 · 2017: 23 · 2016: 26 · 2015: 33 · 2014: 21 · 2013: 18 · 2012: 1
- FWCI
- 23.65
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- University of Chicago
- National Institutes of Health (UL1TR000064)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK 20595, DK-55267, R01DK055267, P60DK020595, P30DK020595)
- National Center for Advancing Translational Sciences
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- beta-cell mass, beta-cell neogenesis, pancreatic islets, beta-cell proliferation, alpha cells, delta cells, somatostatin, glucagon, insulin, ductal cells, human lifespan, diabetes compensation, insulin resistance
- MeSH terms
- Adolescent, Adult, Aged, Autopsy, Cell Count, Child, Child, Preschool, Fluorescent Antibody Technique, Humans, Infant, Infant, Newborn, Infant, Premature, Islets of Langerhans, Middle Aged, Neurons, Pancreatic Hormones, Biomarkers, Paraffin Embedding, Pancreas, Exocrine, Cell Proliferation, Insulin-Secreting Cells, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.